`
`Phigenix Better Drugs for a Better Life
`
`HOME WHO ARE WE?
`
`OUR PRODUCTS
`
`CONTACT US
`
`LATEST NEWS
`
`Company Overview
`
`Headquartered in Atlanta, Georgia, PHIGENIX, Inc. will leverage licensed patented technology to establish a
`strong firstmover advantage in Personalized Medicine and forge a lasting leadership position in the rapidly
`evolving cancer diagnostic and therapeutics industry. The PHIGENIX technology platform involves detecting
`and targeting the PAX2 and EN2 oncogenes for cancer diagnosis and treatment.
`
`We are currently developing diagnostic tests which may detect prostate abnormalities at the premalignant
`state years before the onset of cancer. Our therapeutics in development involves blocking the expression of
`cancer causing proteins and the subsequent reexpression of a naturally occurring component of the
`immune system to fight cancer. Finally, we are developing novel drugs, antibodies and antibodydrug
`conjugates to deactivate the cancer causing protein for cancer treatment and/or prevention.
`
`Recent research findings have provided a better understanding of breast cancer resistance to chemotherapy
`through the discovery of useful biomarkers. It is thought that treatment recommendations for breast cancer
`patients may be tailored through the use of tumor genomic profiling, as well as analysis of host
`characteristics. PHIGENIX is developing a diagnostic kit which determines the levels of a key oncogene that
`is known to regulate drug response in breast cancer, which may assist physicians in determining treatment
`regime. With this diagnostic test, breast cancer patients likely to benefit maximally from a particular therapy
`can be identified, and other patients for whom alternative therapies (e.g. hormonal manipulation) can be
`selected.
`
`What We Offer
`
`Our technology platform focuses on the use
`of novel molecular therapeutics which target
`the immune system to prevent and fight
`prostate cancer. We also have IP covering
`diagnostic kits for the early detection of
`prostate cancer and for the diagnosis of
`breast cancer.
`
`Contact Us
`
`PHIGENIX, Inc. 191 Peachtree Street Suite
`3200 Atlanta, GA 30303 (404) 9461811 Tel
`(404) 9461894 Fax Email:
`info@phigenix.com
`
`1. p.mp3 00:01
`
`
`
`Copyright 2011. Phigenix Pharmaceutical Company. All rights reserved.
`
`Home Our Products Who Are We? Contact Us
`
`Latest New s
`
`http://phigenix.com/
`
`1/1
`
`IMMUNOGEN 2161, pg. 1
`Phigenix v. Immunogen
`IPR2014-00676
`
`